Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)

China flag China · Delayed Price · Currency is CNY
9.17
-0.03 (-0.33%)
Jun 6, 2025, 2:45 PM CST
20.82%
Market Cap 10.69B
Revenue (ttm) 9.69B
Net Income (ttm) 546.88M
Shares Out 1.17B
EPS (ttm) 0.47
PE Ratio 19.34
Forward PE 23.16
Dividend 0.21 (2.30%)
Ex-Dividend Date May 16, 2025
Volume 11,461,820
Average Volume 17,398,519
Open 9.20
Previous Close 9.20
Day's Range 9.10 - 9.25
52-Week Range 6.76 - 9.72
Beta 0.66
RSI 53.95
Earnings Date Aug 19, 2025

About SHA:600267

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was fo... [Read more]

Sector Healthcare
Founded 1956
Employees 7,994
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600267
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.